REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Peta MBAL - Sofiya EAD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Peta Mnogoprofilna Bolnitsa Za Aktivno Lechenie - Sofiya EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Fifth MHAT Sofia is a successor of "Klimentinskata" hospital, founded in 1891.
Since 2009 the hospital is fully-owned by Sofia Municipality.
It is a partner of National Health Insurance Fund.
In 2009 the hospital provided services to 132,218 patients.

Headquarters
zh.k. Banishora bul. Stoletov 67A
Sofia; Sofia - city; Postal Code: 1233

Contact Details: Purchase the Peta MBAL - Sofiya EAD report to view the information.

Basic Information
Total Employees:
Purchase the Peta MBAL - Sofiya EAD report to view the information.
Outstanding Shares:
Purchase the Peta MBAL - Sofiya EAD report to view the information.
Registered Capital:
Purchase the Peta MBAL - Sofiya EAD report to view the information.
Financial Auditors:
Purchase the Peta MBAL - Sofiya EAD report to view the information.
Incorporation Date:
February 28, 2001
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Medicinski Centar Kniaginia Klementina - 06 EOOD
Company Performance
Financial values in the chart are available after Peta MBAL - Sofiya EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
14.29%▲
Total operating revenue
34.5%▲
Operating profit (EBIT)
219.33%▲
EBITDA
53.24%▲
Net Profit (Loss) for the Period
247.59%▲
Total assets
12.53%▲
Total equity
40.01%▲
Operating Profit Margin (ROS)
7.42%▲
Net Profit Margin
6.63%▲
Return on Equity (ROE)
17.08%▲
Quick Ratio
0.2%▲
Cash Ratio
0.16%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo